A Case Report of Multifactorial Cardiac Arrest During Anesthetic Induction in a High-Risk Patient
Keywords:
lidocaine, anesthetic administration, bradycardia, cardiac arrestAbstract
A 73-year-old Thai male patient weighing 72 kg with comorbidities of diabetes, hypertension, and stage 4 chronic kidney disease received regular medications including atenolol, hydralazine, and enalapril. He was scheduled for surgery to treat urinary tract calculi. Prior to enter the operating room, he received atenolol 50 mg and manidipine 20 mg. During anesthesia induction, propofol 140 mg, cisatracurium 8 mg, succinylcholine 100 mg, fentanyl 100 mcg, and intravenous 2% lidocaine with preservative 40 mg (0.56 mg/kg) were administered. Lidocaine was given two minutes before endotracheal intubation to reduce airway reflexes. During intubation, the patient developed bradycardia (HR 50 bpm), severe hypotension (BP 60/40 mmHg), and unpalpable pulse. Electrocardiogram revealed pulseless electrical activity. The patient received two cycles of cardiopulmonary resuscitation along with atropine and adrenaline until circulation returned. Post-CPR, troponin I levels increased from 10.11 to 3,861.5 pg/mL; consequently, the surgery was aborted, and he was transferred to the intensive care unit. The provisional diagnosis was Local Anesthetic Systemic Toxicity induced by lidocaine, affecting the central nervous and cardiovascular systems, leading to cardiac arrest. Contributing factors potentially triggering this event included advanced age, severe chronic kidney disease, and preoperative administration of atenolol and manidipine, as well as the synergistic effects of lidocaine, propofol, fentanyl, succinylcholine, and cisatracurium that induced hypotension, bradycardia, and arrhythmias. This event emphasizes the importance of risk factor and drug interaction assessments in anesthetic practice.
References
DailyMed. Lidocaine hydrochloride injection, solution: drug label [Internet]. Bethesda (MD): National Library of Medicine; 2026 [cited 2026 Jun 1]. Available from: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a1418e2-b208-4e5c-b5f8-21b3a691a578
Siddiqui BA, Kim PY. Anesthesia stages. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2026 Jun 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557596
Baxter Healthcare Ltd. Propofol 20 mg/ml emulsion for injection/infusion: summary of product characteristics [Internet]. London: Electronic Medicines Compendium (EMC), Datapharm Ltd; 2025 [cited 2026 Jun 1]. Available from: https://www.medicines.org.uk/emc/product/11294/smpc
Hameln pharma Ltd. Fentanyl 50 micrograms/ml injection: summary of product characteristics [Internet]. London: Electronic Medicines Compendium (EMC), Datapharm Ltd; 2024 [cited 2026 Jun 1]. Available from: https://www.medicines.org.uk/emc/product/2852/smpc
Hikma Pharmaceuticals USA Inc. Succinylcholine chloride injection, for intravenous or intramuscular use. [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2022 [cited 2026 Jun 1]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215143s003lbl.pdf
DailyMed. Cisatracurium besylate injection: drug label [Internet]. Bethesda (MD): National Library of Medicine; 2026 [cited 2026 Jun 1]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed91f65b-e002-43bd-bfa0-5ce8b89119e6
Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail’s clinical anesthesiology. 7th ed. New York: McGraw-Hill; 2022.
DailyMed. Atenolol tablet: drug label [Internet]. Bethesda (MD): National Library of Medicine; 2025 [cited 2026 Jun 1]. Available from: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96dd038f-b363-4e24-9c67-82b7c85c3bc4
Millimed Co., Ltd. Manidipine 20 mg tablet product information [Internet]. Nonthaburi: National Drug Information, Thai Food and Drug Administration; 2020 [cited 2026 Jun 1]. Available from: https://ndi.fda.moph.go.th/uploads/drug_detail_corporation/doc/word/1163/c43235ca7f89ea2a27633d08b0741354-a1.pdf
Oliver TI, Rudman J, Ahmed I, Grossman SA. Pulseless electrical activity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2026 Jun 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513349
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45. doi: 10.1038/clpt.1981.154.
OpenAnesthesia. Angiotensin-converting enzyme inhibitors [Internet]. San Francisco: International Anesthesia Research Society; 2025 [cited 2026 Jun 1]. Available from: https://www.openanesthesia.org/keywords/angiotensin-converting-enzyme-inhibitors/
DailyMed. Hydralazine hydrochloride tablets: drug label [Internet]. Bethesda (MD): National Library of Medicine; 2026 [cited 2026 Jun 1]. Available from: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4aa1b3e8-9389-fe2c-e063-6294a90a7fb9
Waters CM, Pelczar K, Adlesic EC, Schwartz PJ, Giovannitti JA. ACE-inhibitor or ARB-induced refractory hypotension treated with vasopressin in patients undergoing general anesthesia for dentistry: two case reports. Anesth Prog. 2022;69(3):30-35. doi: 10.2344/anpr-69-02-06.
Beth Israel Deaconess Medical Center, Department of Anesthesia. Commonly used anesthetic medications [Internet]. Boston: BIDMC; [cited 2026 Jun 1]. Available from: https://anesthesia.bidmc.harvard.edu/ADEL/Documents/med_list.pdf
Drugs.com. Atenolol and lidocaine drug interactions: professional co-administration data [Internet]. Auckland: Drugs.com Drug Information Investment Trust; 2026 [cited 2026 Jun 27]. Available from: https://www.drugs.com/drug-interactions/atenolol-with-lidocaine-273-0-1464-0.html?professional=1
UK Clinical Pharmacy Association (UKCPA). Handbook of perioperative medicines: atenolol [Internet]. Leicester: UKCPA; 2024 [cited 2026 Jun 27]. Available from: https://periop-handbook.ukclinicalpharmacy.org/drug/atenolol/?highlight=atenolol
Rehman B, Sanchez DP, Patel P, Shah S. Atenolol. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2026 Jun 27]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539844/
Geladari EV, Vallianou NG, Evangelopoulos A, Koufopoulos P, Panagopoulos F, Margellou E, et al. Cardiac troponin levels in patients with chronic kidney disease: "markers of high risk or just noise"? Diagnostics. 2024;14(20):2316. doi: 10.3390/diagnostics14202316
Verkaik BJ, van der Werf C, Fischer JC, Tukkie R, Umans VAWM, Dekkers P, et al. Cardiac troponin for the diagnosis of acute myocardial infarction in patients after out-of-hospital cardiac arrest. Resuscitation. 2025;215:110774. doi: 10.1016/j.resuscitation.2025.110774.
American Heart Association. Ejection fraction heart failure measurement [Internet]. Dallas (TX): American Heart Association; 2025 [cited 2026 Jun 1]. Available from: https://www.heart.org/en/health-topics/heart-failure/diagnosing-heart-failure/ejection-fraction-heart-failure-measurement
American Heart Association. 2025 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care: algorithms [Internet]. Dallas (TX): American Heart Association; 2025 [cited 2026 Jun 1]. Available from: https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines/algorithms
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Association of Hospital Pharmacy (Thailand)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความในวารสารเภสัชกรรมโรงพยาบาลเผยแพร่ภายใต้เงื่อนไขของสัญญาอนุญาตครีเอทีฟคอมมอนส์ในรูปแบบที่ต้องอ้างอิงแหล่งที่มา - ห้ามใช้เพื่อการค้า - ห้ามแก้ไขดัดแปลง เวอร์ชั่น 4.0 (CC BY-NC-ND 4.0) สามารถแจกจ่ายและนำบทความไปใช้ประโยชน์เพื่อการศึกษาได้แต่ต้องระบุการอ้างอิงถึงบทความจากเว็บไซต์วารสารเภสัชกรรมโรงพยาบาล ไม่สามารถนำบทความไปใช้เพื่อการพาณิชย์ใด ๆ เว้นแต่ได้รับอนุญาตจากบรรณาธิการวารสารเภสัชกรรมโรงพยาบาล และกรณีมีการนำบทความไปเรียบเรียงใหม่ เปลี่ยนแปลงเนื้อหา หรือเสริมเติมแต่งเนื้อหาของบทความ ท่านไม่สามารถนำบทความที่ปรับแต่งไปเผยแพร่ได้ในทุกกรณี
ข้อความที่ปรากฏในบทความในวารสารเป็นความคิดเห็นส่วนตัวของผู้แต่งแต่ละท่านไม่เกี่ยวข้องกับสมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) และบุคลากรในสมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้แต่งแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้แต่งแต่ละท่านจะรับผิดชอบบทความของตนเอง ตลอดจนความรับผิดชอบด้านเนื้อหาและการตรวจร่างบทความเป็นของผู้แต่ง ไม่เกี่ยวข้องกับกองบรรณาธิการ

.png)